Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 153

1.

Porcine Prediction of Pharmacokinetic Parameters in People: A Pig in a Poke?

Tang H, Mayersohn M.

Drug Metab Dispos. 2018 Nov;46(11):1712-1724. doi: 10.1124/dmd.118.083311. Epub 2018 Aug 31.

PMID:
30171162
2.

Should estimates of glomerular filtration rate and creatinine clearance be indexed to body surface area for drug dosing?

Nix DE, Mayersohn M, Erstad BL.

Am J Health Syst Pharm. 2017 Nov 1;74(21):1814-1819. doi: 10.2146/ajhp160467. Epub 2017 Sep 25. No abstract available.

PMID:
28947625
3.

Letter to the editor.

Mayersohn M.

Curr Ther Res Clin Exp. 2011 Jun;72(3):138-9. doi: 10.1016/j.curtheres.2011.05.001. No abstract available.

5.

Controversy in the allometric application of fixed- versus varying-exponent models: a statistical and mathematical perspective.

Tang H, Hussain A, Leal M, Fluhler E, Mayersohn M.

J Pharm Sci. 2011 Feb;100(2):402-10. doi: 10.1002/jps.22316. Epub 2010 Sep 22.

PMID:
20862773
6.

Formulation and in vivo evaluation of chlorpropham (CIPC) oral formulations.

Kuehl PJ, Brenner T, Jain PK, Karlage K, Sepassi K, Yang G, Mayersohn M, Yalkowsky SH, Myrdal PB.

J Pharm Sci. 2008 Dec;97(12):5222-8. doi: 10.1002/jps.21384.

PMID:
18383335
7.
8.

Interspecies prediction of human drug clearance based on scaling data from one or two animal species.

Tang H, Hussain A, Leal M, Mayersohn M, Fluhler E.

Drug Metab Dispos. 2007 Oct;35(10):1886-93. Epub 2007 Jul 23.

11.

A porcine model for fixed drug eruptions in humans: the case of antipyrine in the Yucatan micropig.

Pak Y, Stollberg-Zagar K, Mayersohn M.

J Appl Toxicol. 2006 Jan-Feb;26(1):1-4.

PMID:
16307469
12.

A novel model for prediction of human drug clearance by allometric scaling.

Tang H, Mayersohn M.

Drug Metab Dispos. 2005 Sep;33(9):1297-303. Epub 2005 Jun 15.

13.

Accuracy of allometrically predicted pharmacokinetic parameters in humans: role of species selection.

Tang H, Mayersohn M.

Drug Metab Dispos. 2005 Sep;33(9):1288-93. Epub 2005 May 26.

14.
15.

Efficacy of sustained low-efficiency dialysis in the treatment of salicylate toxicity.

Lund B, Seifert SA, Mayersohn M.

Nephrol Dial Transplant. 2005 Jul;20(7):1483-4. Epub 2005 Mar 29. No abstract available.

PMID:
15797887
16.

Dermal absorption of camphor, menthol, and methyl salicylate in humans.

Martin D, Valdez J, Boren J, Mayersohn M.

J Clin Pharmacol. 2004 Oct;44(10):1151-7.

PMID:
15342616
17.

Protein expression pattern of P-glycoprotein along the gastrointestinal tract of the Yucatan micropig.

Tang H, Pak Y, Mayersohn M.

J Biochem Mol Toxicol. 2004;18(1):18-22.

PMID:
14994275
18.

Sensitive and rapid isocratic liquid chromatography method for the quantitation of curcumin in plasma.

Pak Y, Patek R, Mayersohn M.

J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Nov 5;796(2):339-46.

PMID:
14581073
19.

Measurement of disposition half-life, clearance, and residence times.

Mayersohn M.

Curr Protoc Toxicol. 2001 May;Chapter 5:Unit5.3. doi: 10.1002/0471140856.tx0503s04.

PMID:
20949436
20.

Pharmacokinetics tricks and traps: drug dosage adjustment in renal failure.

Boxenbaum H, Tannenbaum S, Mayersohn M, Oleson F.

J Pharm Pharm Sci. 1999 Jan-Apr;2(1):2-4. No abstract available.

21.
22.
23.

Human moricizine metabolism. II. Quantification and pharmacokinetics of plasma and urinary metabolites.

Pieniaszek HJ Jr, Davidson AF, Chaney JE, Shum L, Robinson CA, Mayersohn M.

Xenobiotica. 1999 Sep;29(9):945-55.

PMID:
10548454
24.

Moricizine bioavailability via simultaneous, dual, stable isotope administration: bioequivalence implications.

Pieniaszek HJ Jr, Mayersohn M, Adams MP, Reinhart RJ, Barrett JS.

J Clin Pharmacol. 1999 Aug;39(8):817-25.

PMID:
10434234
25.

Sensitive and selective gas chromatographic methods for the quantitation of camphor, menthol and methyl salicylate from human plasma.

Valdez JS, Martin DK, Mayersohn M.

J Chromatogr B Biomed Sci Appl. 1999 Jun 11;729(1-2):163-71.

PMID:
10410939
26.

Estimation of Ki in a competitive enzyme-inhibition model: comparisons among three methods of data analysis.

Kakkar T, Boxenbaum H, Mayersohn M.

Drug Metab Dispos. 1999 Jun;27(6):756-62.

28.

A modified equilibrium dialysis technique for measuring plasma protein binding: experimental evaluation with diazepam and nortriptyline.

Chow HH, Khor SP, Lee HC, Mayersohn M.

Pharm Res. 1998 Oct;15(10):1643-6. No abstract available.

PMID:
9794511
29.

Enantiomeric determination of amphetamine and methamphetamine in urine by precolumn derivatization with Marfey's reagent and HPLC.

Foster BS, Gilbert DD, Hutchaleelaha A, Mayersohn M.

J Anal Toxicol. 1998 Jul-Aug;22(4):265-9.

PMID:
9681327
30.

The influence of cimetidine on the disposition kinetics of the antidepressant venlafaxine.

Troy SM, Rudolph R, Mayersohn M, Chiang ST.

J Clin Pharmacol. 1998 May;38(5):467-74.

PMID:
9602962
33.

Allometric analysis of organ extraction ratios.

Tannenbaum S, Boxenbaum H, Mayersohn M.

J Pharm Sci. 1997 Nov;86(11):1319-20. No abstract available.

PMID:
9383748
34.

Absorption, disposition, and metabolism of trans-methyl styryl ketone in female B6C3F1 mice.

Sauer JM, Bao J, Smith RL, Kuester RK, Mayersohn M, Sipes IG.

Drug Metab Dispos. 1997 Oct;25(10):1184-90.

35.

p-Hydroxymethamphetamine enantiomer pharmacokinetics and metabolism in rats: absence of N-demethylation.

Hutchaleelaha A, Mayersohn M.

Biopharm Drug Dispos. 1997 Jul;18(5):423-32.

PMID:
9210980
36.

Oral and topical absorption, disposition kinetics, and the metabolic fate of trans-methyl styryl ketone in the male Fischer 344 rat.

Sauer JM, Smith RL, Bao J, Kattnig MJ, Kuester RK, McClure TD, Mayersohn M, Sipes IG.

Drug Metab Dispos. 1997 Jun;25(6):732-9.

37.

Absorption, disposition kinetics, and metabolic pathways of cyclohexene oxide in the male Fischer 344 rat and female B6C3F1 mouse.

Sauer JM, Bao J, Smith RL, McClure TD, Mayersohn M, Pillai U, Cunningham ML, Sipes IG.

Drug Metab Dispos. 1997 Mar;25(3):371-8.

38.

Simple apparatus for serial blood sampling in rodents permitting simultaneous measurement of locomotor activity as illustrated with cocaine.

Hutchaleelaha A, Sukbuntherng J, Mayersohn M.

J Pharmacol Toxicol Methods. 1997 Feb;37(1):9-14.

PMID:
9086283
39.

Comparative pharmacokinetics and interspecies scaling of amphotericin B in several mammalian species.

Hutchaleelaha A, Chow HH, Mayersohn M.

J Pharm Pharmacol. 1997 Feb;49(2):178-83.

PMID:
9055191
40.

Absorption and disposition kinetics of 3,3',4,4'-tetrachloroazoxybenzene in the male Fischer 344 rat.

Ziegler TL, Pillai UA, Smith RL, Kattnig MJ, Liebler DC, Mayersohn M, Sipes IG.

Drug Metab Dispos. 1996 Sep;24(9):1009-14.

PMID:
8886612
41.

Antiphencyclidine monoclonal Fab fragments reverse phencyclidine-induced behavioral effects and ataxia in rats.

Valentine JL, Mayersohn M, Wessinger WD, Arnold LW, Owens SM.

J Pharmacol Exp Ther. 1996 Aug;278(2):709-16.

PMID:
8768722
42.

Characterization of the properties of cocaine in blood: blood clearance, blood to plasma ratio, and plasma protein binding.

Sukbuntherng J, Martin DK, Pak Y, Mayersohn M.

J Pharm Sci. 1996 Jun;85(6):567-71.

PMID:
8773950
43.

Pharmacokinetics of the aldose reductase inhibitor tolrestat: studies in healthy young and elderly male and female subjects and in subjects with diabetes.

Fruncillo R, Troy S, Parker V, Mayersohn M, Hicks D, Kraml M, Battle M, Chiang S.

Clin Pharmacol Ther. 1996 Jun;59(6):603-12.

PMID:
8681485
44.
45.

3,3',4,4'-tetrachloroazobenzene absorption, disposition, and metabolism in male Fischer 344 rats.

Pillai UA, Ziegler TL, Wang DX, Kattnig MJ, McClure T, Liebler DC, Mayersohn M, Sipes IG.

Drug Metab Dispos. 1996 Feb;24(2):238-44.

PMID:
8742237
46.

Clinical pharmacokinetics of the monoamine oxidase-A inhibitor moclobemide.

Mayersohn M, Guentert TW.

Clin Pharmacokinet. 1995 Nov;29(5):292-332. Review.

PMID:
8582117
47.

Pharmacokinetics of amphotericin B in rats as a function of dose following constant-rate intravenous infusion.

Chow HH, Wu Y, Mayersohn M.

Biopharm Drug Dispos. 1995 Aug;16(6):461-73.

PMID:
7579028
48.
49.
50.

Pharmacokinetics in the elderly.

Mayersohn M.

Environ Health Perspect. 1994 Dec;102 Suppl 11:119-24. Review.

Supplemental Content

Loading ...
Support Center